Georgia’s Aversi Now Selling Riga Virus Cancer Treatment
Latvian scientists have arrived in Georgia to present first virotheraphy medicine – Riga Virus (Rigvir), which is now available in Aversi pharmacy. It is one of the most easy-to-use methods for cancer treatment, which is gradually being proven throughout the world.
The Rigvir virus, once injected into the human body, finds cancer cells and destroys them, also activating the immune system and improving the quality of life of the patient. It is not genetically modified, can be used on an outpatient basis and does not have side effects.
Rigvir can cure Melanoma, Colorectal, Stomach, Pancreatic, Kidney, Uterine, Bladder, Lung, Prostate Cancers and Sarcoma of several types. Long-term clinical studies and a few thousand people who tried out this medicine on themselves confirm the success of the treatment. It does not cause any side effects except a temperature of 37.2 degrees for a few days after injection.
“Studies into this virus began in 1960, so we can say that this is one of the most studied viruses and the results are accurate. Almost all of our patients went into remission. That said, according to our estimates, about 30% of patients are not affected by Rigvir because they have special proteins that neutralize the virus. But we have already figured out how to block the action of these proteins and improve the medicine,” said Prof. Ivars Kalvins, Chairman of the Scientific Council and Representative of the International Virotherapy Center.
Prof. Kalvins also recommends alternating the Rigvir injection with radiation and chemotherapy to achieve a better effect, but not both at the same time. “It is known that, during chemotherapy, the immune system becomes greatly weakened, and Rigvir needs to have a strong immune system to attack cancer cells with double the power,” he explained.
Rigvir can even be used to treat melanoma, one of the most common types of cancer, and today one of the most progressive cancers.
“In Georgia, the risk of melanoma and skin cancer is quite high,” said Dr. Lali Mekokishvili, Dermatovenerolog, and the President of Georgian Association of Photodermatology and Skin Cancer. “Many people use solariums and it is dangerous in the sun here but people don’t use skin protection creams. At the same time, it is difficult to identify this cancer in its early stages, and it is very difficult to treat with chemotherapy. Therefore, any new medications in this area will save patients. And Rigvir has a really impressive performance in this regard.”
In the framework of their visit to Georgia, Latvian scientists held a seminar for fifty Georgian oncologists who now have the full right to use Rigvir in treating patients.
“This virus was developed by Latvian scientists, and we are pleased to come to Georgia and share our experiences with local doctors,” said Dr. Kaspars Losans, Medical Director of International Vinotherapy Center. “It has proven itself in our homeland. Moreover, people from all over the world come to Latvia to get Rigvir, so we are very happy that now local patients here will have the opportunity to buy this medicine in Georgia.”
Rigvir was officially registered by the Ministry of Labor, Health and Social Affairs of Georgia on February 15, 2015 and is already available in Aversi pharmacy at #148 David Agmashenebeli Avenue. The price of one bottle is 1,050 Lari.
Eka Karsaulidze